219 related articles for article (PubMed ID: 26739617)
1. Predictors of advanced colorectal neoplasia at initial and surveillance colonoscopy after positive screening immunochemical faecal occult blood test.
Botteri E; Crosta C; Bagnardi V; Tamayo D; Sonzogni AM; De Roberto G; de Leone A; Lowenfels A; Maisonneuve P
Dig Liver Dis; 2016 Mar; 48(3):321-6. PubMed ID: 26739617
[TBL] [Abstract][Full Text] [Related]
2. Can quantification of faecal occult blood predetermine the need for colonoscopy in patients at risk for non-syndromic familial colorectal cancer?
Levi Z; Rozen P; Hazazi R; Vilkin A; Waked A; Maoz E; Birkenfeld S; Niv Y
Aliment Pharmacol Ther; 2006 Nov; 24(10):1475-81. PubMed ID: 17032281
[TBL] [Abstract][Full Text] [Related]
3. Predictors of advanced colorectal neoplasia for colorectal cancer screening.
Wong MC; Lam TY; Tsoi KK; Chan VC; Hirai HW; Ching JY; Sung JJ
Am J Prev Med; 2014 May; 46(5):433-9. PubMed ID: 24745632
[TBL] [Abstract][Full Text] [Related]
4. Risk stratification for advanced colorectal neoplasia according to fecal hemoglobin concentration in a colorectal cancer screening program.
Auge JM; Pellise M; Escudero JM; Hernandez C; Andreu M; Grau J; Buron A; López-Cerón M; Bessa X; Serradesanferm A; Piracés M; Macià F; Guayta R; Filella X; Molina R; Jimenez W; Castells A;
Gastroenterology; 2014 Sep; 147(3):628-636.e1. PubMed ID: 24937264
[TBL] [Abstract][Full Text] [Related]
5. Favorable lifestyle before diagnosis associated with lower risk of screen-detected advanced colorectal neoplasia.
Knudsen MD; de Lange T; Botteri E; Nguyen DH; Evensen H; Steen CB; Hoff G; Bernklev T; Hjartåker A; Berstad P
World J Gastroenterol; 2016 Jul; 22(27):6276-86. PubMed ID: 27468217
[TBL] [Abstract][Full Text] [Related]
6. Screening for colorectal cancer and advanced colorectal neoplasia in kidney transplant recipients: cross sectional prevalence and diagnostic accuracy study of faecal immunochemical testing for haemoglobin and colonoscopy.
Collins MG; Teo E; Cole SR; Chan CY; McDonald SP; Russ GR; Young GP; Bampton PA; Coates PT
BMJ; 2012 Jul; 345():e4657. PubMed ID: 22833618
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals.
Lieberman DA; Prindiville S; Weiss DG; Willett W;
JAMA; 2003 Dec; 290(22):2959-67. PubMed ID: 14665657
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with false-positive and false-negative fecal immunochemical test results for colorectal cancer screening.
Wong MC; Ching JY; Chan VC; Lam TY; Luk AK; Ng SS; Sung JJ
Gastrointest Endosc; 2015 Mar; 81(3):596-607. PubMed ID: 25293827
[TBL] [Abstract][Full Text] [Related]
9. Immunochemical testing of individuals positive for guaiac faecal occult blood test in a screening programme for colorectal cancer: an observational study.
Fraser CG; Matthew CM; Mowat NA; Wilson JA; Carey FA; Steele RJ
Lancet Oncol; 2006 Feb; 7(2):127-31. PubMed ID: 16455476
[TBL] [Abstract][Full Text] [Related]
10. Faecal occult blood screening: knowledge, attitudes, and practice in four Hong Kong primary care clinics.
Tam TK; Ng KK; Lau CM; Lai TC; Lai WY; Tsang LC
Hong Kong Med J; 2011 Oct; 17(5):350-7. PubMed ID: 21979470
[TBL] [Abstract][Full Text] [Related]
11. Interval faecal occult blood testing in a colonoscopy based screening programme detects additional pathology.
Bampton PA; Sandford JJ; Cole SR; Smith A; Morcom J; Cadd B; Young GP
Gut; 2005 Jun; 54(6):803-6. PubMed ID: 15888788
[TBL] [Abstract][Full Text] [Related]
12. Association between lifestyle and site-specific advanced colorectal lesions in screening with faecal immunochemical test and sigmoidoscopy.
Knudsen MD; Botteri E; Holme Ø; Hjartåker A; Song M; Thiis-Evensen E; Norvard ER; Schult AL; Randel KR; Hoff G; Berstad P
Dig Liver Dis; 2021 Mar; 53(3):353-359. PubMed ID: 33309513
[TBL] [Abstract][Full Text] [Related]
13. Aspirin users attending for NHS bowel cancer screening have less colorectal neoplasia: chemoprevention or false-positive faecal occult blood testing?
Lee TJ; Hull MA; Rajasekhar PT; Clifford GM; Ritchie M; James P; McNally RJ; Rutter MD; Rees CJ
Digestion; 2012; 85(4):278-81. PubMed ID: 22538301
[TBL] [Abstract][Full Text] [Related]
14. Faecal immunochemical test mitigates risk of delayed colonoscopy in people with elevated risk of colorectal neoplasia.
Wassie MM; Young GP; Cock C; Bampton P; Winter JM; Simpson K; Saluja H; Chuang A; Fraser RJ; Symonds EL
J Gastroenterol Hepatol; 2022 Jun; 37(6):1067-1075. PubMed ID: 35261071
[TBL] [Abstract][Full Text] [Related]
15. Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
Zorzi M; Senore C; Da Re F; Barca A; Bonelli LA; Cannizzaro R; Fasoli R; Di Furia L; Di Giulio E; Mantellini P; Naldoni C; Sassatelli R; Rex D; Hassan C; Zappa M;
Gut; 2015 Sep; 64(9):1389-96. PubMed ID: 25227521
[TBL] [Abstract][Full Text] [Related]
16. The Asia-Pacific Colorectal Screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects.
Yeoh KG; Ho KY; Chiu HM; Zhu F; Ching JY; Wu DC; Matsuda T; Byeon JS; Lee SK; Goh KL; Sollano J; Rerknimitr R; Leong R; Tsoi K; Lin JT; Sung JJ;
Gut; 2011 Sep; 60(9):1236-41. PubMed ID: 21402615
[TBL] [Abstract][Full Text] [Related]
17. A combination of clinical risk stratification and fecal immunochemical test results to prioritize colonoscopy screening in asymptomatic participants.
Aniwan S; Rerknimitr R; Kongkam P; Wisedopas N; Ponuthai Y; Chaithongrat S; Kullavanijaya P
Gastrointest Endosc; 2015 Mar; 81(3):719-27. PubMed ID: 25708760
[TBL] [Abstract][Full Text] [Related]
18. Lifestyle predictors for non-participation and outcome in the second round of faecal immunochemical test in colorectal cancer screening.
Knudsen MD; Berstad P; Hjartåker A; Gulichsen EH; Hoff G; de Lange T; Bernklev T; Botteri E
Br J Cancer; 2017 Aug; 117(4):461-469. PubMed ID: 28704841
[TBL] [Abstract][Full Text] [Related]
19. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.
Lieberman DA; Weiss DG;
N Engl J Med; 2001 Aug; 345(8):555-60. PubMed ID: 11529208
[TBL] [Abstract][Full Text] [Related]
20. Fecal hemoglobin concentration is useful for risk stratification of advanced colorectal neoplasia.
Kim NH; Kwon MJ; Kim HY; Lee T; Jeong SH; Park DI; Choi K; Jung YS
Dig Liver Dis; 2016 Jun; 48(6):667-72. PubMed ID: 27012445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
